VistaGen Therapeutics
VTGN
#9358
Rank
A$0.10 B
Marketcap
$3.47
Share price
-5.13%
Change (1 day)
-51.84%
Change (1 year)

EPS for VistaGen Therapeutics (VTGN)

EPS in 2023 (TTM): -$9.70

According to VistaGen Therapeutics 's latest financial reports the company's current EPS (TTM) is -$10.08. In 2022 the company made an earnings per share (EPS) of -$14.61 an increase over its 2021 EPS that were of -$15.18.

EPS history for VistaGen Therapeutics from 2008 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$9.70-33.59%
2022-$14.61-3.71%
2021-$15.1824.49%
2020-$12.19-55.17%
2019-$27.20-37.59%
2018-$43.58-32.16%
2017-$64.24-72.04%
2016-$229.76-84.16%
2015-$1,451298.71%
2014-$363.8783.45%
2013-$198.34-83.24%
2012-$1,18393.91%
2011-$610.16
2010N/A
2009N/A
2008N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-66.20%๐Ÿ‡บ๐Ÿ‡ธ USA